Source: Eur Respir J, 50 (2) 1601357; 10.1183/13993003.01357-2016



Rating:

Share or cite this content

Citations should be made in the following way:
Maria G. Belvisi, Mark A. Birrell. The emerging role of transient receptor potential channels in chronic lung disease. Eur Respir J, 50 (2) 1601357; 10.1183/13993003.01357-2016

Member's Comments

No comment yet.

Related content which might interest you: The central role of CFTR in lung disease Source: International Congress 2016 – What can respiratory medicine learn from cystic fibrosis research? Year: 2016 Classical transient receptor potential channel 6 (TRPC6) is a key regulator of acute hypoxic pulmonary vasoconstriction Source: Eur Respir J 2007; 30: Suppl. 51, 55s Year: 2007 ENaC inhibition in cystic fibrosis: potential role in the new era of CFTR modulator therapies Source: Eur Respir J, 56 (6) 2000946; 10.1183/13993003.00946-2020 Year: 2020 The role of the epigenetic regulator HMGN5 in COPD resulting from chronic lung injury Source: ERS Lung Science Conference 2017 Year: 2017 Transcriptome profiling reveals a potential role for antagonism of the calcium-sensing receptor in the prophylaxis of idiopathic pulmonary fibrosis Source: Virtual Congress 2021 – Novel insights into the pathogenesis of chronic lung diseases Year: 2021 Role of the CFTR gene in determining chronic pulmonary diseases in the paediatric population Source: Eur Respir J 2001; 18: Suppl. 33, 155s Year: 2001 The role of calcium metabolism assessment in the clinical setting of interstitial lung diseases Source: Virtual Congress 2021 – Moving forward in various aspects of sarcoidosis Year: 2021 Is there a role for endothelin-1 receptor antagonists in the treatment of lung fibrosis associated with pulmonary hypertension? Source: Eur Respir J, 52 (2) 1801287; 10.1183/13993003.01287-2018 Year: 2018 Toll-like receptor (TLR)-signaling mediates enhanced inflammatory effects in coinfections of viral and bacterial respiratory pathogens in human lung tissue – A new approach to the pathogenesis of COPD exacerbations? Source: Annual Congress 2011 - Insight into mechanisms of respiratory infections Year: 2011 Targeting EGFR signalling in chronic lung disease: therapeutic challenges and opportunities Source: Eur Respir J 2014; 44: 513-522 Year: 2014 Transient receptor potential vanilloid 4 channels mediate resistive breathing-induced acute lung injury. Source: Virtual Congress 2020 – Scientific advances in airway pharmacology Year: 2020 The role of lipoxin A4 and its receptor in pathogenesis of inflammatory lung diseases Source: Annual Congress 2010 - Novel markers of lung injury Year: 2010 Role of airway smooth muscles in chronic airway inflammation and lung fibrosis and possible therapeutic potential of endothelin receptor antagonism Source: Annual Congress 2010 - New mechanisms in lung development, acute and chronic lung diseases Year: 2010 The role of purinergic P2X7 receptors on lipopolysaccharide (LPS)-induced lung injury Source: Annual Congress 2007 - Acute and chronic lung injury and its repair: novel molecular insight Year: 2007 The lung microbiome in obstructive airways disease: potential pathogenetic roles Source: Eur Respir Monogr 2019; 83: 140-157 Year: 2019 Platelets: a potential role in chronic respiratory diseases? Source: Eur Respir Rev, 30 (161) 210062; 10.1183/16000617.0062-2021 Year: 2021 The role of chronic inflammation in mouse lung tumourigenesis Source: Annual Congress 2005 - Pathophysiology of lung cancer progression: impact in diagnosis and early detection Year: 2005